Tag: NASDAQ: FATE

Business

Analysts Reflect On Various Pharmaceutical Companies Following The End of ASCO

With the American Society of Clinical Oncology Annual Meeting coming to an end, there was a range of abstract presentation highlights for biotech and pharma investors and analysts.  Tazeen Ahmad gives Buy rating to Fatem Incyte and ADC therapeutics  For instance, BoA Securities analyst Tazeen Ahmad highlighted several companies, including […]